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LINE-1 (L1) elements are the most abundant autonomous non-LTR retrotransposons in the human genome. Having recently
performed a meta-analysis of L1 endonuclease-mediated retrotranspositional events causing human genetic disease, we have ex-
tended this study by focusing on two key issues, namely, mutation detection bias and the multiplicity of mechanisms of target
gene disruption. Our analysis suggests that whereas an ascertainment bias may have generally militated against the detection of
autosomal L1-mediated insertions, autosomal L1 direct insertions could have been disproportionately overlooked owing to their
unusually large size. Our analysis has also indicated that the mechanisms underlying the functional disruption of target genes by
L1-mediated retrotranspositional events are likely to be dependent on several diﬀerent factors such as the type of insertion (L1
direct, L1 trans-driven Alu, or SVA), the precise locations of the inserted sequences within the target gene regions, the length of the
inserted sequences, and possibly also their orientation.
Copyright © 2006 Jian-Min Chen et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
LINE-1 (long interspersed element-1) or L1 elements ac-
count for ∼17% of the human genome sequence [1]. How-
ever, of > 500,000 L1 copies, only ∼ 80–100 are capable of
active retrotransposition [2]. Retrotranspositionally compe-
tent L1 elements are typically 6.0kb in length and L1 retro-
transposition is thought to occur by target-site-primed re-
verse transcription [3–5]. Apart from simple self-insertion,
L1 retrotransposition can alter the primary structure of the
human genome in a variety of diﬀerent ways (6,7,8,9).
Recently, we performed a comprehensive meta-analysis
of 48 L1 endonuclease-mediated retrotranspositional events
that cause human genetic disease. This analysis explored the
sequence features associated with the diﬀerent L1-mediated
human retrotransposons (ie, L1 direct insertions, L1 trans-
driven Alu insertions, and L1 trans-driven SVA (short in-
terspersed nucleotide elements-R, variable number of tan-
dem repeats, and Alu insertions)), the frequency of genomic
deletions created upon L1-mediated retrotransposition, and
the process of L1-mediated insertion [6]. Here, we have ex-
tended this analysis by focusing on two key issues namely,
mutation detection bias and the multiple mechanisms of tar-
get gene disruption. Note that during the preparation of this
review, three further examples of simple Alu insertions caus-
ing human disease have been reported; these were also in-
cluded in the analysis (Table 1).
MUTATION DETECTION DISPLAYS
A SIGNIFICANT BIAS
Since the ﬁrst report that de novo L1 insertions into the fac-
tor VIII gene (F8) had caused severe haemophilia A [7],
numerous examples of simple L1-mediated retrotransposi-
tional events (ie, those involving no loss of target gene ma-
terial; n = 42) have been identiﬁed as a cause of human ge-
neticdisease(Table 1).Baseduponresultsfrominvitrostud-
ies [8, 9], we have systematically annotated disease-causing2 Journal of Biomedicine and Biotechnology













methodd Reference poly (A) within the target
tail (bp) geneb
Simple insertions
APC 5q L1 Ta 520/S 222 E15 —e Southern blotting [56]
CHM Xq L1 Ta 6017/AS 71 E6 (+35; −82) Skipping of E6 Initially failed to
[22]
amplify exon 6
CYBB Xp L1 Ta 836/S 69 I5 (+1864; −278) Complex splicing RT-PCR [23]
CYBB Xp L1 Ta 1722/S 101 E4 — Southern blotting [57]
DMD Xp L1 Ta 1400/S 38 E48 — Southern blotting [58]
DMD Xp L1 Ta 530/AS 73 5’-UTR
(see text)
No expression of
RT-PCR [45] muscle form
transcript
F8 Xq L1 Ta 3800/S 54 E14 — Southern blotting [7]
F8 Xq L1 preTa 2300/AS 77 E14 — Southern blotting [7]
F9 Xq L1 Ta 463/S 68 E5 — Not speciﬁed [59]
F9 Xq L1 Ta 163/S 125 E7 — PCR [60]
HBB 11p L1 Ta 6000/AS 107 I2 (+765; −85) Reduced mRNA Southern blotting [41, 61]
expression (15%)
RP2 Xp L1 Ta 6000/S 64 I1 (+633; −15641) No mRNA Southern blotting [24]
expression
RPS6KA3 Xp L1 HS 2800/AS Yesf I3 (+5177; −8) Skipping of E4 Initially failed to
[40]
amplify exon 4
APC 5q AluYb8 278/S 40 E15 — PCR [62]
BCHE 3q AluYb9 289/S 38 E2 — Southern blotting [63]
BRCA1 17q AluS 286/S Yesf E11 — Protein truncation test [21]
BRCA2 13q AluYc1 281/S 62 E22 (+36; −163) Skipping of E22 PCR [25]
BRCA2 13q AluYa5 285/S Yesf E3 Skipping of E3 Southern blotting [21]
BTK Xq AluY— / A S — E 8 — P C R [ 64, 65]
BTK Xq AluY 281/S 74 E9 — PCR [15]
CASR 3q AluYa5 280/AS 93 E7 — PCR [66]
CLCN5 Xp AluYa5 281/S 50 E11 Skipping of E11 PCR [26, 32]
CRB1 1q AluY— / A S 7 0 E 7 — P C R [ 67]
EYA1 8q AluYa5 —/AS 97; 31g E10 — Southern blotting [68]
F8X q AluYb9 288/AS 37 I18 (+1734; −5) Skipping of E19 PCR [35]
F9X q AluYa5a2 244/S 78 E5 — Southern blotting [69]
F9X q AluYa5a2 237/S 39 E5 — PCR [70]
F9X q AluY 279/AS 40 E8 — Not speciﬁed [59]
FGFR2 10q AluYa5 283/AS 69 I8 (−2) Skipping of E9 PCR [36]
FGFR2 10q AluYb8 288/AS 47 E9 — PCR [36]
GK Xp AluYc1 241/AS 74 I4 (+13629; −42) See text PCR [39]
HESX1 3p AluYb8 288/S 30 E3 Complex splicing PCR [27]
HMBS 11q AluYa5 279/AS 39 E5 (+32; −18) No mRNA PCR [28]
expression
IL2RG Xq AluYa5 —/AS — I7 (−17) — PCR [64, 65]
NF1 17q AluYa5 282/AS 40 I40 (+134; −27) Skipping of E41 Southern blotting [37]
SERPING1 11q AluYc1 285/S 42 I6 — Not speciﬁed [71]
TNFRSF6 10q AluYa5 281/AS 33 I7 (+1212; −50) Skipping of E8 RT-PCR [38]
ZFHX1B 2q AluYa5 281/S 93 E8 — PCR [72]




region of intron 1
in a homozygous
patient
BTK Xq SVA 491/S 74 E9 (+51; −26) Skipping of E9 Initially failed to
[48]
amplify E9 by PCR
FCMD 9q SVA 3062/S Yesf 3’-UTR (see text) Nearly no Southern blotting [51]
expression
SPTA1 1q SVA 632/S 50 E5 (+60; −87) Skipping of E5 RT-PCR [49]Jian-Min Chen et al 3
Table 1: Continued
Genomic deletions associated with L1-mediated retrotransposons
DMD Xp L1 Ta 608/AS (Δ1bp) 16 E44 (+145; −3) Skipping of E44 PCR [54]
FCMD 9q L1 Ta 1200/S (Δ6bp) 59 I7 (+2527; −24) Complex splicing Southern blotting [55]




APC 5q AluYb9 93/AS (Δ1599bp) 60 E14 NA In vitro synthesized- [52]
protein assay
F8X q AluYb8 290/AS (Δ2bp) 47 E14 — Southern blotting [73]
SERPINC1 1q Alu 6/AS (Δ1444bp) 40 I3b NA Southern blotting [53]
Genomic deletions associated with only simple poly (A) insertions
AGA 4q NA NA/AS (Δ2076bp) 37 I8 NA RT-PCR [74]
BRCA2 13q NA NA/S (Δ6212bp) 35 I13 NA Southern blotting [75]
COL4A6 Xq NA NA/AS (Δ > 40kb) 70 I2 NA Southern blotting [76]
∗The entries are presented in the same order as in Table 2 from Chen et al [6] for easy comparison, except for the addition of three simple Alu insertions
(BRCA1 [21]; BRCA2 [21]; and HESX1 [27]) that have been reported during the preparation of this review. Data on chromosomal location, inserted element
and orientation, insertion size, and length of poly (A) tail were derived from Table 2 in Chen et al [6].
aWith respect to the sense strand of the disrupted gene. S, sense; AS, antisense. The lengths of the genomic deletions associated with L1-mediated
retrotransposons and simple poly (A) insertions are indicated in parentheses.
bI, intron; E, exon. When an insertion occurred into an intron/exon and accompanying RNA analysis data were available, the position of the insertion’s
integration site was indicated in parentheses (+, relative to the ﬁrst nucleotide of the intron/exon; −, relative to the last nucleotide of the intron/exon).
cOnly the eﬀect on the target gene’s pre-mRNA splicing and/or mRNA expression was evaluated.
dThe method that initially suggested/identiﬁed the mutation at the nucleotide level. PCR indicates all PCR-based techniques using genomic DNA as
templates.
eData not available.
fPoly (A) tail present but number of residues not speciﬁed.
g97bp in the aﬀected mother and 31bp in the aﬀected daughter, respectively.
hNot applicable.
L1-mediated retrotranspositional events that have been as-
sociated with genomic deletions (n = 9; Table 1). All these
events probably resulted from L1 endonuclease-dependent
retrotranspositional activity because not only have all the
inserts integrated at typical L1-endonuclease cleavage sites,
but they also possess poly (A) tails (see [6, Tables 1 and 2
and Figure 3]). By contrast, the three L1-derived extra-short
inserts (termed “hyphen elements” by Audr´ ezet et al [10])
identiﬁed at the junctions of large genomic deletions [10–
12] did not share the above two hallmark characteristics
of L1 endonuclease-dependent retrotranspositional events.
These three mutations have therefore been proposed to have
arisen via a “repair” process for existing DNA lesions, an L1
endonuclease-independent mechanism [13] that is likely to
be qualitatively diﬀerent from L1 endonuclease-based inser-
tional mutagenesis (see [6, Table 1]).
The above 51 L1 endonuclease-mediated retrotranspo-
sitional events account for ∼ 0.1% of known mutations
(∼ 52,000 as of April 2005) causing human genetic disease,
based upon the data collated in the Human Gene Muta-
tionDatabase(http://www.hgmd.org/;[14]).Theoccurrence
of L1-mediated simple retrotranspositional events has how-
ever long been thought to have been underestimated since
large insertions may often be overlooked by routinely used
PCR-based mutation detection techniques (eg, [15, 16]). In
this review, we have sought to explore how this mutation de-
tection bias could have operated. To this end, we ﬁrst manu-
ally evaluated the original publications that reported the 51
L1 endonuclease-mediated retrotranspositional events with
respect to the mutation detection method(s) that initially
suggested/identiﬁed the presence of an insertion or dele-
tion at the nucleotide (ie, DNA or RNA) level. The loca-
tions of these lesions within the target genes (ie, in the 5 -
untranslated regions (UTRs), exons, introns, or 3 -UTRs,
resp) were also systematically annotated. Then, in order to
assess the likelihood of having underestimated the occur-
rence of this type of mutational event, we attempted to re-
late the chromosomal location of the aﬀected genes, as well
as the types, sizes, and precise locations of the inserted se-
quence within the genes, to the mutation detection methods
employed (Table 1).
In the context of the analysis of possible mutation detec-
tion bias, we excluded, for reasons of simplicity, the follow-
ing entries from further consideration: (i) the three large ge-
nomic deletions that were associated with only simple poly
(A) insertions, since the type of L1-mediated retrotranspo-
son involved is unknown (Table 1) and (ii) the SVA simple
insertions, owing to their limited number (only 4; Table 1).
Our primary focus has therefore been the L1 and Alu in-
sertions, both of which have been frequently found to cause
human genetic disease. In addition, we did not consider the
42 simple insertions separately from the 6 genomic deletions
associated with L1-mediated retrotransposons, on the basis
that all were considered to have resulted from the same L1
endonuclease-mediated insertional mechanism. However, it
is important to emphasize that, of the latter 6 cases, three4 Journal of Biomedicine and Biotechnology
Table 2: X-chromosome/autosome comparison with respect to gene number, disease genes, known mutations, and retrotranspositional
insertion events.






in HGMDe insertions causing insertions causing Size (Mb)a genes in the
genetic disease genetic disease human genomeb
A: X chromosome 11 12 155 1,098 895 124 10010
B: autosomes+Y 18 3 3045 ∼ 39,000 14,977 1877 42155
(A/B) % 65.1 400 5.1 2.8 6.0 6.6 23.8
a,bData from [20].
cData from OMIM ( http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM&itool=toolbar) as of April 2005.
d,eData from HGMD (http://www.hgmd.org/) as of April 2005.
events were associated with extremely short target gene dele-
tions (Δ1bp in DMD; Δ6bp in FCMD;a n dΔ2bp in F8)
yet contain relatively long inserts (Table 1); they were thus
treated here as simple insertions. By contrast, the three Alu
insertions that are associated with large genomic deletions
(Δ4726bp in ABCD1; Δ1599bp in APC;a n dΔ1444bp in
SERPINC1) were treated as simple large genomic deletions
since in all cases, the inserted Alu sequences plus the poly (A)
tails are rather short (Table 1).
Since a typical Alu sequence is invariably < 290bp in
length and the poly (A) tails associated with L1-mediated
retrotransposons are usually < 100bp (see also [6, Table 4]),
the length of an Alu insert plus its poly (A) tail should be
< 400bp (Table 1). At ﬁrst sight, it would appear unlikely
that those Alu inserts which cause sex-linked disease are go-
ing to be signiﬁcantly underestimated both because X-linked
diseases readily come to clinical attention in males and be-
cause inserts of < 400bp into male X chromosomes are read-
ily identiﬁable by routine PCR-based methods. Indeed, as is
evident from Table 1, only in rare cases have the simple Alu
inserts that have become integrated into the X chromosome
been detected by Southern blotting or RT-PCR, and these
would also have been amenable to detection by routine PCR-
basedmethods.Whilstanelectrophoreticbandoflargerthan
the expected size was demonstrated in the cases of Alu inser-
tionswhenPCRproductswereexamined,failuretoPCRam-
plifyseveralexonswasencounteredinthecaseofthe4726bp
deletion involving the X-linked ABCD1 gene [17].
To date, whereas 11 Alu insertions have been identiﬁed in
X-linked genes as a cause of human genetic disease in male
patients, the comparable ﬁgure for the autosomes is only 18
(Table 1). Although the X chromosome has been claimed
to be a preferred target for retrotransposition [18, 19], it
is diﬃcult to accept that the observed chromosomal distri-
bution of retrotranspositional mutations reﬂects the actual
distribution since the X chromosome comprises only ∼ 5%
of the human genome [20]. Consequently, it would appear
likely that at least a proportion of Alu insertions causing
human autosomal disease have been overlooked by routine
PCR-based techniques. This could have been due to prefer-
ential PCR ampliﬁcation of the wild-type allele which would
have “masked” the Alu insertion mutant allele, an example
being the failure to detect two Alu insertions by routinely
used methods [21].
L1 direct inserts are usually much longer than Alu inserts
(Table 1).Although,inprinciple,thepresenceoflargeinserts
in X-linked genes in males might be initially suggested by
the failure to PCR amplify the exon(s) under investigation
(eg, as in the case of the 6017bp L1 insertion in the CHM
gene [22]), most of the L1 direct insertions listed in Table 1
were reported to have been initially identiﬁed by RT-PCR
or Southern blotting. Given the extensive eﬀorts devoted to
screening for X-linked disease (note particularly the identi-
ﬁcation of two inserts that had become integrated into deep
intronic regions (CYBB [23]; RP2 [24])), we surmise that the
current ﬁgure (n = 12) of L1 direct inserts into the X chro-
mosome may approach complete ascertainment. In this con-
text, it is noteworthy that with respect to the insertions caus-
ing human X-linked disease, the number of reported L1 di-
rect insertions (n = 12) is approximately the same as that of
reported Alu insertions into X-linked genes (n = 11). How-
ever, by comparison with disease-causing Alu insertions that
have become integrated within autosomal genes (n = 18),
an apparent paucity of disease-causing autosomal L1 direct
inserts (n = 3) is evident (Table 1). The reason for this ﬁnd-
ing may be quite simple: the longer the inserts are, the more
easily will they be missed by routine PCR-based techniques
in the presence of a wild-type allele. It is therefore not un-
reasonable to conclude that the occurrence of L1 direct in-
sertions causing autosomal disease has probably been signif-
icantly underestimated.
To obtain further insights into this issue, we examined
the above ﬁnding in the context of a multiple pairwise com-
parison(Table 2).Thisrevealedthat,ingeneral,mutationsin
X-linked genes are signiﬁcantly over-represented in HGMD
by comparison with both the proportion of X-linked to
non-X-linked genes in HGMD (4-fold; p<0.0001), and
the proportion of X-linked to non-X-linked genes in the
genome as a whole (8-fold; p<0.0001). This could be
due to a number of diﬀerent factors including (i) the X
chromosome bearing a slightly higher proportion of genes
that are “disease genes” than other chromosomes, (ii) X-
linked disease may come to clinical attention more readily
than autosomal disease since recessive mutations will be-
come manifest in hemizygous males, (iii) hemizygous in-
sertional mutations on the X-chromosome may, using cur-
rently used mutation detection techniques, be more read-
ily detectable than heterozygous/compound heterozygousJian-Min Chen et al 5
insertional mutations on the autosomes (due to the inher-
ent limitations of PCR/“masking” of the mutant allele by
the wild-type allele), (iv) greater eﬀort may have been ex-
pended, historically, in identifying the genes and characteriz-
ing the mutational spectra underlying X-linked disease, and
(v) the X-chromosome may represent a preferred retrotrans-
positional target as compared to other chromosomes. In re-
ality, a combination of all these diﬀerent factors has probably
been operating. These considerations are also likely to apply
to retrotranspositional insertions and may together account
for the discrepancy in the observed prevalence of insertions
into the X-chromosome as compared with the autosomes.
MULTIPLE MECHANISMS OF TARGET
GENE DISRUPTION
Wealsosystematicallysurveyedtheoriginalpublicationsthat
reported the 51 L1 endonuclease-mediated retrotransposi-
tional events with respect to the evidence presented for func-
tional disruption of the target genes at the RNA level (ie,
aberrant splicing and/or decreased mRNA expression). The
information obtained was further evaluated in the context of
thesize,orientation,andintegrationsitesoftheinsertswher-
e v e rp o s s i b l ea n da p p r o p r i a t e( Table 1).
Simpleinsertions
Aluinsertions
Of the 18 simple Alu insertions that integrated within coding
regions, only ﬁve were informative with respect to the func-
tionaldisruptionofthetargetgenesattheRNAlevel(BRCA2
[25]; BRCA2 [21]; CLCN5 [26], HESX1 [27]; HMBS [28]).
This was in sharp contrast to the 7 simple Alu insertions that
are known to have become integrated into intronic regions,
5 of which were informative. The probable reason for this
phenomenon is that Alu insertions into coding regions will
invariably lead to the loss of a functional protein product, ir-
respective of the precise point at which the gene expression
pathway has been disrupted.
The Alu insertion into exon 22 of the BRCA2 gene re-
sulted in the skipping of the exon involved through “some
unknown mechanism” [25]. With hindsight, this insertion,
which integrated fairly deeply into the exon involved (36bp
aftertheﬁrstnucleotideand163bpbeforethelastnucleotide
of exon 22; Table 1), could have disrupted cis-splicing ele-
ments such as an exon splicing enhancer or/and could have
interactedwithtrans-actingcellularsplicingfactors,resulting
in the “silencing” of the upstream constitutional splice ac-
ceptor site (for reviews, see [29–31]). Consistent with this
postulate, the Alu insertion in the CLCN5 gene [32]w a s
recently suggested to interfere with splicing regulatory ele-
ments, resulting in exon 11 skipping [26]. However, this is
certainly not the case for the Alu insertion into exon 5 of
the HMBS gene: both in vitro expression studies and in vivo
RT-PCR analyses demonstrated that the mutant HMBS al-
lele was not expressed at the RNA level [28]. Of the various
possible mechanisms proposed by the original authors, we
favour nonsense-mediated mRNA decay [33, 34].
All 5 informative Alu intronic insertions are located
nearer to the downstream exons than to the preceding exons.
Consequently, most of them (n = 4) were found to cause
skipping of the downstream exons: whilst two most likely af-
fect the correct recognition of the splice acceptor sites (F8
[35]; FGFR2 [36]), the other two may aﬀect the branch site
thatisusuallylocatedveryclosetotheendoftheintron(NF1
[37]; TNFRSF6 [38]). The remaining intronic insertion (GK
[39]) was, however, reported not to “cause any deletions,
duplications, premature stop codons, or frameshifts in the
individual with benign glycerol kinase deﬁciency, as deter-
mined by RT-PCR (data not shown).” This notwithstanding,
since no other mutations were present within the coding re-
gions and intron-exon boundaries of the gene, and since the
Alu insertion does not represent a polymorphism, this in-
sertion was concluded to be indeed disease-causing [39]. Al-
though we concur with this conclusion, we nevertheless feel
that the functional consequence(s) of the Alu insertion may
have been overlooked. In this regard, it is worth pointing out
that the patient’s radiochemically measured GK activity was
32% (ie, not a complete loss) that of the mean normal con-
trol[39].ItisthereforepossiblethattheAlu insertiondidnot
completely disrupt normal pre-mRNA splicing. However, in
the RT-PCR analysis, the aberrantly spliced transcripts may
have been unstable and could thus have been “masked” by
correctly spliced stable transcripts.
L1insertions
As with the Alu simple insertions, only one of the 8 L1 sim-
ple insertions in coding regions was informative with respect
to target gene disruption; it caused the skipping of the exon
involved [22], probably through a similar mechanism to the
above-discussed Alu insertion into the BRCA2 gene [25]. By
contrast, all 4 intronic insertions were informative: whilst
two insertions were associated with either the skipping of a
single exon (RPS6KA3 [40]) or an extremely complex splic-
ing pattern (CYBB [23]), the other two insertions resulted in
a signiﬁcant, or even complete, loss of the mRNA transcript
(HBB [41]; RP2 [24]). The latter two examples will now be
discussed in detail in the light of a recent report [42].
Both L1 RNA and open-reading-frame-2 (ORF2) pro-
tein are very diﬃcult to detect in mammalian cells, suggest-
ing a mammalian-speciﬁc mechanism for negatively regu-
lating L1 expression (see [42] and references therein). In-
deed, the A-rich sense strand of an active human L1 element
(ie, LINE-1.3; [43]), containing many canonical (n = 19)
and noncanonical (n = 141) polyadenylation signals, has
been noted to be prone to generate truncated transcripts by
prematurepolyadenylation,atleastunderinvitroconditions
[44]. However, using a diﬀerent cell culture assay, Han et
al [42] have shown that poor expression of the ORF2 protein
is mainly due to the inability of RNA polymerase to elon-
gateeﬃcientlythroughL1codingsequences(despiteaminor
contribution from premature polyadenylation). Moreover,
these authors have demonstrated that an ORF2 sequence,6 Journal of Biomedicine and Biotechnology
when placed in the antisense orientation, inhibits transcrip-
tion primarily by promoting premature polyadenylation.
Based upon these observations, Han et al [42] predicted that
L1 elements which have become inserted into introns could
attenuate the expression of target genes either by prema-
ture truncation of RNA (in the antisense orientation) or by
promoting transcriptional elongation (in the sense orienta-
tion), both mechanisms resulting in the decreased produc-
tionoffull-lengthpre-mRNA.Consistentwiththispostulate,
highly expressed genes were found to contain relatively small
amounts of L1 sequence, whereas poorly expressed genes
contained large amounts [42].
In particular, the full-length de novo L1 insertion into
intron 1 of the RP2 gene that is associated with the com-
p l e t el o s so fRP2 mRNA synthesis [24] was cited by Han et
al [42] as an example to support their thesis. As is evident
from Table 1, the L1 insert in the HBB gene [41] shares re-
markable similarities with that found in the RP2 gene [24]:
both are full-length and both became integrated within in-
trons. However, whereas the full-length RP2 L1 insertion was
in the sense orientation and resulted in the complete loss
of gene expression, the full-length HBB L1 insertion was in
the antisense orientation and the amount of mRNA tran-
scribed from the aﬀected allele was reduced to 30% of nor-
mal (the mRNA transcripts from the aﬀected and unaﬀected
alleles were distinguishable by a codon 2 polymorphism and
no splicing variants were detected [41]). This concurs with
the in vitro ﬁnding that “inserting ORF2 in the antisense
orientation produced a similar, but less potent, decrease in
full-length RNA” [42]. Thus, the HBB insertion may serve as
an additional example of an insertion that is consistent with
the proposal that the insertion of L1 elements into a target
gene’s introns can signiﬁcantly alter the expression of that
gene [42].
Theabovenotwithstanding,itwouldappearunlikelythat
the signiﬁcantly 5 -truncated L1 insert (only 530bp) in the
DMD gene [45] caused the complete loss of the muscle (M)
isoform of dystrophin through inhibition of transcriptional
elongation and/or premature polyadenylation; this conclu-
sion is based upon the in vitro observation that the level
of reporter RNA expression was inversely correlated with
the length of transfected L1 ORF2 (see [42, Figure 3]). In-
deed, this short insert, which had integrated just 28bp up-
stream of the ATG codon initiating translation of the M iso-
form encoded by the dystrophin (DMD) gene, must have af-
fected transcriptional initiation and/or regulation. Although
the expression of the M isoform was completely abolished,
there were compensatory increases in the expression of the
nonmuscle B (brain) and CP (cerebellar Purkinje) isoforms
in the patient’s skeletal muscle [45, 46]. (The M, B, and CP
isoformsaregenerallyconsideredtobefunctionallyhomolo-
gous. However, the transcripts encoding these isoforms con-
tain a unique ﬁrst exon and are expressed from diﬀerent,
tissue-speciﬁc promoters, see [47] and references therein.)
SVAinsertions
Of the four SVA insertions (Table 1), two were inserted into
exons causing the skipping of the exons involved (BTK [48];
SPTA1 [49]), whereas the other two were reported to be as-
sociated with virtuallyundetectable mRNA expression (ARH
[50]; FCMD [51]). In the case of the ARH mutation, “al-
thoughnomRNAwasdetectablebyNorthernblotting,small
amounts of cDNA could be ampliﬁed using RT-PCR” [50].
Similarly,“thetranscriptofthis(FCMD)genewasnearlyun-
detectable in FCMD patients who carried the insertion ho-
mozygously, and signiﬁcantly lower than normal in patients
heterozygous for the insertion and another mutation haplo-
type” [51]. As previously discussed [6], although SVA ele-
ments are relatively poorly characterized, they are composed
of highly repetitive sequences (for a detailed sequence de-
scription, see [51]; refer also to [50, Figure 2]). Importantly,
bothSVAinsertionsareratherlong(2600and3062bp,resp).
Moreover, the SVA insertion in ARH [50] is very similar to
the L1 insertion in RP2 [24] in the following respects: both
were in the sense orientation and both had been inserted
into the ﬁrst introns of their respective genes in compara-
ble locations (Table 1). Thus, it is tempting to speculate that
the 2600bp SVA insert may also compromise transcriptional
elongation resulting in an undetectable level of mRNA (even
although it is C-rich, cf L1 which is A-rich).
That the 3062bp SVA element had been inserted into the
3 -UTR of the FCMD gene [51]e ﬀectively serves to exclude
a possible eﬀect on transcriptional initiation. It is also perti-
nent to note that the normal FCMD transcript comprises a
long 3 -UTR of 5952bp; the SVA integration site is 4375bp
downstreamoftheTGAtranslationalterminationcodonand
1454bp upstream of the poly (A) addition signal sequence.
Thus, it is very likely that the 3062bp SVA insertion (in sense
orientation) may either inhibit transcriptional elongation or
cause abnormal polyadenylation resulting in the complete
loss of gene expression.
GenomicdeletionsassociatedwithL1-mediated
retrotranspositionalevents
In the 6 cases associated with large target gene deletions (ie,
the 3 events associated with L1-mediated retrotransposons
(ABCD1 [17]; APC [52]; SERPINC1 [53]) plus the 3 events
associated with only a simple poly (A) tail (Table 1)), the role
played by L1-mediated short insertions in the functional dis-
ruptionofthetargetgenescannotbeindependentlyassessed.
Of the three events associated with extremely short genomic
deletions, only two are informative: whilst the 608bp L1 in-
sertion in exon 44 of the DMD gene caused the skipping
of the exon involved [54], the 1200bp L1 insertion into in-
tron 7 of the FCMD gene yielded a complex splicing pattern
including the skipping of exons 7 and 8, the skipping of only
exon 7, and the skipping of exons 7, 8, and 9, respectively
[55].
CONCLUSIONS
Mutation detection bias is a complex issue. This notwith-
standing, our analysis has suggested that at least two factors
(namely, clinical selection and the choice of mutation detec-
tiontechniques)mayhavecontributedtoasigniﬁcantbiasinJian-Min Chen et al 7
detecting L1-mediated retrotranspositional events that cause
human genetic disease. Although there is a general tendency
for autosomal L1-mediated insertions to be overlooked, au-
tosomal L1 direct insertions appear likely to be the most se-
riously underestimated owing to their unusually large size.
In particular, given the two examples of L1 direct inserts
that have integrated within deep intronic regions (CYBB
[23]; RP2 [24]), it would appear that methods other than
PCR-based techniques (eg, RT-PCR and Southern blotting)
should be employed whenever necessary and possible, with a
view to maximizing the mutation detection rate.
Our analysis has also demonstrated that the mechanisms
underlying the functional disruption of target genes by L1-
mediated retrotranspositional events are dependent on sev-
eral factors such as the type of insertion, the precise loca-
tions of the inserted sequences within the target gene re-
gions, the length of the inserted sequences, and perhaps also
their orientation. Thus, an Alu insert might not be capable
of eﬃciently inhibiting transcriptional elongation owing to
its small size. Moreover, inserts that have integrated within
5 -o r3  -UTRs would be likely to aﬀect the target genes dif-
ferently from those that have integrated within coding or in-
tronic regions. Further, the unique examples of full-length
L1 inserts integrated into intronic regions (HBB [41]; RP2
[24]) suggest that both the length and orientation of L1 in-
serts may be important in the context of transcriptional in-
hibition. This notwithstanding, the precise mechanisms un-
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